Who founded Ampriondx?

Ampriondx was founded by Russell Lebovitz, Claudio Soto, Russ Lebovitz in 2007.

Who are Ampriondx's investors?

Ampriondx's investors include Snatched Ventures.

How much funding has Ampriondx raised?

Ampriondx has disclosed $16.7M raised across 2 rounds.

Where is Ampriondx headquartered?

Ampriondx is headquartered in San Francisco, US.

Ampriondx

San Francisco, US · Founded 2007 · Delaware corporation · 1 known investors

ampriondx.com ↗

Amprion develops seed amplification assay (SAA) diagnostic tests that detect misfolded proteins in biological fluids as biomarkers for neurodegenerative diseases such as Parkinson's, Lewy body pathologies, and Alzheimer's. Its clinical lab offers tests like SYNTap/SAAmplify-ɑSYN for clinicians to aid early diagnosis of these brain diseases.

BiotechDigital HealthMedical Devices

Founders & leadership

Ampriondx was founded in 2007 by Russell Lebovitz, Claudio Soto, and Russ Lebovitz.

Russell Lebovitz inCo-founder · CEOVenture Partner at BootstrapLabs

Claudio SotoCo-founder

Russ LebovitzCo-founder

Peter ClintonNamed on SEC filing

Board

Marc ChanDirector & Stockholder

Rahul BhansaliBoard director

Kenneth LehmanDirector & Stockholder

Investors · 1

Snatched VenturesSan Francisco

Reported raises · per SEC filings

Form D private placements

$16.7M disclosed across 2 rounds · 2022–2024

▶$5.8MraisedSep 2024 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Marc ChanDirector
Russell LebovitzExecutive Officer, Director
Rahul BhansaliDirector

Offering amount: $15M
Amount sold: $5.8M
Proceeds to insiders: $291.5K
First sale: Sep 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11MraisedJul 2022 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Claudio SotoDirector
Marc ChanDirector
Peter ClintonDirector
Kenneth LehmanDirector
Russell LebovitzExecutive Officer, Director

Offering amount: $11M
Amount sold: $11M
Proceeds to insiders: $550K
First sale: Jun 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

CND Life Sciences9 shared keywords

Medscape8 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Ampriondx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Ampriondx do?: Amprion develops seed amplification assay (SAA) diagnostic tests that detect misfolded proteins in biological fluids as biomarkers for neurodegenerative diseases such as Parkinson's, Lewy body pathologies, and Alzheimer's. Its clinical lab offers tests like SYNTap/SAAmplify-ɑSYN for clinicians to aid early diagnosis of these brain diseases.
Who founded Ampriondx?: Ampriondx was founded by Russell Lebovitz, Claudio Soto, Russ Lebovitz in 2007.
Who are Ampriondx's investors?: Ampriondx's investors include Snatched Ventures.
How much funding has Ampriondx raised?: Ampriondx has disclosed $16.7M raised across 2 rounds.
Where is Ampriondx headquartered?: Ampriondx is headquartered in San Francisco, US.